Lets cut through the noise and lock this down
Therefore, we are not proposing to establish an average typical dose different than 100 mg for injectable buprenorphine administered on a monthly basis for purposes of calculating the drug component under the OTP benefit, though we seek comment on whether this average typical dose (100 mg) is close to the dose for the monthly formulation of Brixadi that patients receive on average
For example, as we noted in the CY 2024 PFS proposed rule, 42 CFR 485.713 specifies that when an OTA or PTA provides services at a location that is off the premises of a clinic, rehabilitation agency, or public health agency, those services are supervised by a qualified occupational or physical therapist who makes an onsite supervisory visit at least once every 30 days
We are proposing a work RVU of 0.35 for GIPC1 based on a crosswalk to CPT code 99446, a work RVU of 0.70 for GIPC2 based on a crosswalk to CPT code 99447, a work RVU of 1.05 for GIPC3 based on a crosswalk to CPT code 99448), a work RVU of 1.40 for GIPC4 based on a crosswalk to CPT code 99449, a work RVU of 0.70 for GIPC5 based on a crosswalk to CPT code 99451, and a work RVU of 0.70 for GIPC6 based on a crosswalk to 99452
The speed of action can vary from person to person, but the gum is designed to provide a relatively rapid release of nicotine to help ease the transition away from smoking or vaping